Clay Siegall’s Seattle Genetics is now one of the biggest and leading companies in the world of oncology. Oncology is the science of removing tumors and as you’ve guessed, Clay Siegall’s company’s primary focus in creating drugs that can cure cancer. Clay’s passion for developing drugs have earned him a reputation as bullish in his way of running his company and the continued development of drugs to fight cancer. In one interview, Clay admits that he loves making drugs, but it is not an easy thing to do.
To date, Seattle Genetics has been able to develop innovative drugs that have promising potential in fighting cancer. One such drug is Adcetris, the company’s flagship drug. Adcetris treats Hodgkin lymphoma, a type of cancer in the lymph system that has the potential to spread to other organs. It is now in the testing stage, and if successful, it could be on the market as the first official cure for cancer.
Seattle Genetics is also developing other kinds of drugs. These drugs are mainly for manipulating antibodies, weaponizing them so that they can fight cancer from the inside. The primary model for these medicines is ‘smart bombs,’ with the goal of only killing the cancer cells and minimizing collateral damage to the body.
Seattle Genetics was founded in 1998, and Dr. Siegall is one of its founders. Today Dr. Siegall is the CEO, President, and Chairman of its Board of Directors. Clay Siegall has secured more than $675 million for Seattle Genetics from private and public financing. Before he co-founded Seattle Genetics, Dr. Clay Siegall worked in the Bristol-Myers Squibb Pharmaceutical Research Institute for six years. He was also with the National Cancer Institute from 1988 to 1991.
Dr. Clay Siegall has a B.S. in Zoology, which is a surprise to some people who admire his work as they expect that the specialist had his B.S. in oncology. However, he graduated from the University of Maryland, and then received his Ph.D. in Genetics from George Washington University. From his graduation in genetics, he was able to gather the knowledge and experience that would lead the entrepreneur to enter the field of oncology and tackle drugs, cancer, and research.
Today, Dr. Clay Siegall has conquered a reputation in the field of oncology that makes him one of the most researched scientists of oncology alive today. His work with cancer and some of his theories are inspirational to younger scientists and veterans alike.